Following the company’s second quarter results, Research Capital analyst Andre Uddin is mainta... Read More
New interim clinical data has Research Capital Corporation analyst André Uddin feeling more bullish... Read More
It may not have the buzz of biotech or the cachet of cannabis but the medical device space is defini... Read More
Research Capital analyst André Uddin is sticking with his “Speculative Buy” rating on drug and ... Read More
Calling Theralase Technologies (Theralase Technologies Stock Quote, Chart, News TSXV:TLT) a high-ris... Read More
Analyst André Uddin of Mackie Research says Theralase Technologies (Theralase Technologies Stock Qu... Read More
A new development at Theralase (TSXV:TLT) has Echelon Wealth Partners analyst maintaining his bullis... Read More
Anyone who has lost a family member to cancer knows that scientific progress in beating the disease ... Read More
2010: The Top 20 Canadian Techs (So far) This Year 2009 was a year of recovery for the worldwide mar... Read More
Share
Tweet
pin
Share